Hogeveen H, Huijps K, Lam TJ
N Z Vet J 2011 Jan;59(1):16-23
PMID: 21328153
Abstract
Good udder health is not only important for the dairy farmer but, because of increasing interest of consumers in the way dairy products are produced, also for the dairy production chain as a whole. An important role of veterinarians is in advising on production diseases such as mastitis. A large part of this advice is given around the planning of management to maintain or improve the udder health status of a farm. Mastitis is a costly disease, due to losses (a reduction of output due to mastitis) and expenditure (additional inputs to reduce the level of mastitis). Worldwide, published estimates of the economic losses of clinical mastitis range from €61 to €97 per cow on a farm, with large differences between farms, e.g. in The Netherlands, losses due to clinical and subclinical mastitis varied between €17 and €198 per cow per year. Moreover, farmers tended to underestimate these costs. This indicates that for a large proportion of farms there are many avoidable losses. In order to provide good support to farmers’ decision-making, it is important to describe the mastitis setting not only in terms of disease, e.g. incidence of clinical mastitis, but also in monetary terms; and to make good decisions, it is necessary to provide the dairy farmer with information on the additional expenditure and reduced losses associated with alternative decisions. Six out of 18 preventive measures were shown to have a positive nett benefit, viz blanket use of dry-cow therapy, keeping cows standing after milking, back-flushing of the milk cluster after milking a cow with clinical mastitis, application of a treatment protocol, washing dirty udders, and the use of milkers’ gloves. For those measures that included a large amount of routine labour or investment, the reduced losses did not outweigh the additional expenditure. The advisor cannot expect that measures that are cost-effective are always implemented. Reasons for this are the objectives of the dairy farmer can be other than maximisation of profit, resources to improve the mastitis situation compete with other fields of management, risk involved with the decision, economic behaviour of the dairy farmer, and valuation of the cost factors by the dairy farmer. For all decision-makers this means that, although financial incentives do have an effect on the management of mastitis, it is not always sufficient to show the economic benefits of improved management to induce an improvement of management of mastitis.
In order to calculate the costs of mastitis from model studies, the various cost factors need
to be distinguished. Those most commonly addressed are decreased milk production, veterinary services, diagnostics, drugs, discarded milk, labour, decreased product quality, increased risk of new cases of the same disease or of other diseases, increased risk of culling, and materials for prevention (Hogeveen and Østerås 2005).
人件費、設備投資はちょっと計算に入れるのは難しいかな。新規乳房炎のリスクはモデルを使うほかないな。淘汰頭数はどうすれば知れるかなぁ。
よし、次はこれを読もう。
Huijps K, Lam T, Hogeveen H. Costs of mastitis: facts and perception. Journal of Dairy Research 75, 113–20, 2008